Drupal.behaviors.print = function(context) {window.print();window.close();}>
Dominion Diagnostics, LifeGen Conducting Validation Trial of Genomic Test for Addiction Risk
January 09, 2013
Dominion Diagnostics, LifeGen Conducting Validation Trial of Genomic Test for Addiction Risk
By
Molika Ashford
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail
Molika Ashford
.
Related Stories
Dominion Diagnostics Licenses Rights to LifeGen Genetic Test Technology
December 17, 2012 / GenomeWeb Daily News
Data Supports Oncotype DX for Predicting Recurrence in Node-Positive Cancers, Guiding Radiation Therapy
March 13, 2013 / Pharmacogenomics Reporter
Avellino Lab Launches Genetic Test in US to Identify Risk of Blindness from LASIK Surgery
March 6, 2013 / Pharmacogenomics Reporter
HTG to Commercialize PROOF's COPD Risk Stratification Test; Aims for Launch Next Year
December 5, 2012 / Pharmacogenomics Reporter
Transgenomic to Develop RAS Mutation Test with Amgen for Metastatic CRC Patients
May 15, 2013 / Pharmacogenomics Reporter